Our Research Makes Life Better
6/4/25

UB has been changing the world through research for decades and continues to innovate every day for a safer, healthier and brighter future.

New AI Lab Advances Drug Development and Clinical Research
10/16/25

Murali Ramanathan, PhD, leads the Laboratory for Artificial Intelligence (AI) and Clinical Pharmacology, aiming to improve drug development across a range of diseases.

New Research Targets Painful Side Effect of Cancer Treatment
8/17/26

Jason Sprowl, PhD, has received funding to investigate why a promising cancer drug causes nerve damage in some patients and solutions to prevent this debilitating side effect.

Okere and Team Develop AI to Predict Hospitalization Risk
1/27/26

Arinze Okere, PharmD, MS, MBA, head of the Division of Outcomes and Practice Advancement, led a team in developing AI to predict hospitalization of at-risk patients.

Now Open: Café and Commons at UB SPPS
8/24/26
The Pharmacy Building's new café and recreation space offers grab-and-go dining, games and a welcoming place to connect, study and recharge.
Pharmacists in Kidney Care Teams Improve Patient Outcomes
5/14/26

Calvin Meaney, PharmD, clinical associate professor of pharmacy practice, recently discussed how pharmacists in kidney care teams can optimize medication management.

previous next

Latest News

More News>

Upcoming Events

Loading events…
See All Events>

Degree Programs

  • Online Pharmaceutical Sciences MS in Pharmacometrics and Personalized Pharmacotherapy
    8/4/26
    This new and unique online graduate program focuses on the methodology and application of mathematical models for disease and pharmacological measurement while utilizing extensive training in pharmacokinetics, pharmacodynamics, and systems pharmacology.
  • Pharmaceutical Sciences MS
    7/10/26
    Our MS program is for students who have previously earned a BS degree and wish to acquire high-impact positions in research, industry, education and health care settings. The MS program is research-focused, immersing our students in diverse aspects of drug action, from drug discovery to various elements of drug evaluation.
  • MS in Clinical and Translational Therapeutics
    2/25/26
    The only pharmacy school based program of its kind in the country, our Master of Science in Clinical and Translational Therapeutics provides you with a valuable opportunity to be involved in research and training to combat disease.
  • Pharmaceutical Sciences MS in Pharmacometrics and Personalized Pharmacotherapy
    7/10/26
    This unique graduate program focuses on advanced training in pharmacokinetics (study of absorption, distribution, metabolism and excretion of drugs) and pharmacodynamics (study of drug effects and toxicity in treatment of diseases) to enhance personalized medicine.
  • Pharmaceutical Sciences BS/MS
    7/15/26
    The BS/MS is a five-year accelerated program for academically qualified students who enroll at UB as first-year/freshman students, or who are already enrolled in our BS degree program. Graduates of this program are highly sought after by pharmaceutical companies.
  • Pharmaceutical Sciences BS
    9/30/25
    The BS in Pharmaceutical Sciences is a four-year program that focuses on the design, development and rational use of medication for the prevention and treatment of disease.
  • Doctor of Pharmacy (PharmD)
    10/9/25
    Our Doctor of Pharmacy (PharmD) is a professional degree program that prepares students to be therapeutic drug managers, working as integrated members of the health-care team.
  • Pharmaceutical Sciences PhD
    7/24/26
    Our highly sought-after PhD in Pharmaceutical Sciences is the foremost destination for graduate scholars interested in challenging the boundaries of drug discovery, development and evaluation.

Points of Pride

  • 4/9/24

    Ranked No. 1 pharmacy school in New York State and No. 19 pharmacy school in the country.

    Source: U.S. News & World Report

  • 6/18/24

    We are one of the oldest pharmacy schools in the nation and the first pharmacy school within the State University of New York (SUNY) system.

  • 9/14/23

    We proudly graduate pharmacy leaders—our established network of more than 6,100 active alumni offers mentoring and career guidance to students.

  • 4/22/19

    We are part of the University at Buffalo Academic Health Center, one of only a handful of institutions across the nation that includes the full complement of health schools.

  • 1/27/26

    We offer 21 degree pathways, including dual PharmD degrees, combined university PharmD degrees, BS, BS/MS, MS and PhD.

  • 1/26/24

    We have 29 student organizations: 25 professional student organizations and 4 class governments to develop professionalism and create career opportunities.

  • 9/16/21

    Ranked the 12th most affordable pharmacy program in the U.S.

    Source: College Affordability Guide

  • 11/22/22

    New York’s Flagship

    Recognized for advancing the state’s public higher education mission as a leading center for academics and research.

  • 1/26/24

    Learning and Engagement Communities

    Our students live and learn in Learning and Engagement Communities (LEC), where faculty and staff foster their professional and personal journeys.

  • 1/26/24

    H/S/U PharmD Grading System

    Our Honors/ Satisfactory/ Unsatisfactory (H/S/U) PharmD grading system emphasizes learning over the attainment of traditional letter grades, improving student success and PharmD program quality.

  • 1/26/24

    Renewed PharmD Curriculum

    Our renewed PharmD curriculum provides a more integrated learning experience and a comprehensive path for student success, guiding our PharmD students academically, professionally and personally. 

  • 1/26/24

    Million Dollar Leaders

    Over 50% of our tenure track faculty have $1 million+ research grants.

    Based on 2023 data.

  • 1/26/24

    DDDE Research Hub

    Our Drug Discovery, Development and Evaluation (DDDE) Hub provides creative approaches to support core innovations in drug discovery and development along with the development of a translational therapeutic core.

Learn more about what sets us apart

Faculty Leaders

Developing Drugs to Fight HIV, TB
5/28/26

Gene Morse, PharmD, and faculty investigators have visited Zimbabwe and South Africa to collaborate with research partners focused on developing drugs to combat HIV and tuberculosis, two major public health challenges in the region.

Recognized Among Nation’s Top Inventors
5/28/26

Sathy Balu-Iyer, PhD, was named a 2025 Fellow of the National Academy of Inventors, honoring his extensive contributions to drug development, including more than 50 patents and decades of research in protein therapeutics and immunotherapy.

A Lifetime of Achievements in Pharmaceutical Sciences
1/23/24

William Jusko, PhD, was honored in a special issue edition of the Journal of Pharmaceutical Sciences for his long-term contributions to the advancement of pharmaceutical sciences and his work in the evolution of PK-PD modeling.

Developing Bacteriophages to Fight Drug-Resistant Infections
5/28/26

Nicholas Smith, PharmD, PhD, received a five-year, $3.6 million NIAID grant to develop phage therapies and study their distribution and effectiveness in treating infections.

Accelerating Discoveries of New Drug Targets and Biomarkers
9/3/24

Jun Qu, PhD, is leading a research group using UB's revolutionary new mass spectrometer, the Orbitrap Astral, that aims to accelerate the discovery of new drug targets and biomarkers.

Education and Research in Ambulatory Care Pharmacy
1/23/24

Christ Ange Cellino, PharmD/MBA '19, teaches in ambulatory care, engages in community and global health initiatives, and maintains an experiential training site and research program in ambulatory care pharmacy practice.

Developing Antibiotics to Fight Resistant Bacteria
9/3/24

Yanan (Nancy) Zhao, MD, PhD, received a $4 million grant from NIH to create a novel antibiotic within the class called biamyxins (BMX) to combat the growing issue of antibiotic resistance.

Advancing Clinical Pharmacy and Health Outcomes
10/16/25

Arinze Okere, PharmD, MS, MBA, leads the Division of Outcomes and Practice Advancement, focusing on advancing health outcomes through implementation science, interdisciplinary collaboration and improving care for underserved populations.

Outstanding Career Achievements in Pharmacometrics
1/22/25

Donald Mager, PharmD, PhD, was honored with the prestigious Lewis B. Sheiner Lecturer Award from the International Society of Pharmacometrics for career-long achievements and leadership in the field of pharmacometrics.

 

Advocating for a Broader Scope of Pharmacist Practice
1/22/25

Karl Williams, JD, MBA, BS '80, was appointed the inaugural director of legislative advocacy and will champion expanding the pharmacist scope of practice through reforms in ethics, law and regulation.

Developing Drugs to Treat Ovarian Cancer
11/8/23

Sukyung Woo, PhD, was selected by the National Institutes of Health to serve as a member of its Drug Discovery and Molecular Pharmacology C Study Section. She will contribute to the national biomedical research effort by reviewing cancer-related applications that are potentially useful in cancer therapy of solid tumors and leukemias.

Biopharmaceutical Startup Acquired by Merck
5/28/26

Abceutics, Inc., a preclinical-stage biopharmaceutical startup founded in 2020 by Joseph Balthasar, PhD, and based at UB, was acquired by the global biopharmaceutical company Merck.

Enhancing Student Success and Engagement
1/22/25

Nicole Albanese, PharmD, assistant dean for Student Success and Engagement, provides leadership in the areas of recruiting and admissions, onboarding and academic advisement, registrar, career development and our new learning and engagement communities.

previous next